胰岛素瘤的诊断和手术管理 - - 一个23年的单中心经验
David Hoskovec1,2, Zdeněk Krška1,2, Jan Škrha2,3
11st Department of Surgery, General University Hospital, U nemocnice 2, 12000 Prague, Czech Republic.
Medicina (Kaunas, Lithuania)
|August 26, 2023
概括
手术是胰岛素瘤的主要治疗方法,胰腺瘤是一种罕见的胰腺瘤,会导致低血糖症. 核化在良性病例中是有效的,但由于这种情况很罕见,建议集中治疗.
科学领域:
- 内分泌学 在内分泌学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 胰岛素瘤是一种罕见的胰腺小岛细胞瘤,会导致严重的低血糖症.
- 发病率很低 (每年每百万人中1-2).
- 诊断依赖于惠普尔的三位一体和禁食测试.
研究的目的:
- 审查胰岛素瘤患者的诊断,手术方法和并发症.
- 专注于手术管理的结果.
主要方法:
- 对116名因胰岛素瘤进行手术的患者进行了回顾性观察研究 (2000-2022年).
- 包括禁食测试和CT扫描.
- 收集的数据包括患者人口统计,瘤位置,手术类型和并发症.
主要成果:
- 胰岛素瘤经常位于胰腺体和尾部.
- 核切除是最常见的手术程序.
- 18%的人经历了Clavien-Dindo III级+并发症 (,胰腺).
- 发现了五种恶性胰岛素瘤.
结论:
- 手术是胰岛素瘤的标准治疗方法.
- 对于不涉及主要胰腺管道的良性瘤而言,化足够.
- 由于发病率低,建议集中治疗.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
205
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
205
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Diabetes: Management and Pharmacotherapy
310
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
310
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K


